Literature DB >> 30039870

Chronic generalized pruritus without primary skin lesions: a longitudinal prospective observational study.

Narges Alizadeh1, Seyyed Hossein Mirpour2, Razieh Golmohamadi1, Abbas Darjani1, Hojat Eftekhari1, Rana Rafiei1, Kaveh Gharaei Nejad1, Seyyede Zeinab Azimi1.   

Abstract

Pruritus is among the most common complaints in the field of dermatology. It is also a disturbing symptom of many systemic disorders. Chronic pruritus (CP) refers to the cases of the symptom which last longer than 6 weeks. We conducted a prospective analysis of patients with generalized pruritus without primary skin lesions. All patients underwent primary evaluations and then were followed from 12 to 18 months for further evaluations. Of the 5,127 patients referred to our dermatology clinic, 49 patients with generalized pruritus without primary skin lesions were evaluated. Most of the patients (44%) were in the age group of 40-60 years and female (58%). The duration of pruritus was 37.04 ± 30.4 weeks. Fifty percent of the patients with generalized pruritus had a systemic cause of pruritus. The most common underlying diseases were thyroid disorders (16.67%), diabetes mellitus (12.5%), and malignancy (8.33%). There were no significant statistical differences among the patients in terms of their age, gender, and disease duration with the underlying diseases (P = 0.47, P = 0.99, P = 0.816, respectively). However, the average age of the onset of pruritus was 12 years earlier in the women regardless of the underlying diseases (P = 0.011). Based on the findings of the study, we recommend considering endocrine disorders and malignancies as the most common underlying diseases leading to chronic pruritus without primary skin lesions.
© 2018 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2018        PMID: 30039870     DOI: 10.1111/ijd.14125

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Study of the Involvement of the P2Y12 Receptor in Chronic Itching in Type 2 Diabetes Mellitus.

Authors:  Xiumei Xu; Huiqing Zhang; Lin Li; Runan Yang; Guilin Li; Shuangmei Liu; Günther Schmalzing; Hong Nie; Shangdong Liang
Journal:  Mol Neurobiol       Date:  2022-01-09       Impact factor: 5.590

2.  Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride.

Authors:  Shuhei Yoshikawa; Takeharu Asano; Mina Morino; Keita Matsumoto; Hitomi Kashima; Yudai Koito; Takaya Miura; Yuko Takahashi; Rumiko Tsuboi; Takehiro Ishii; Haruka Otake; Junichi Fujiwara; Masanari Sekine; Takeshi Uehara; Kazuhito Yuhashi; Satohiro Matsumoto; Shinichi Asabe; Hiroyuki Miyatani; Hirosato Mashima
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

3.  Chronic Pruritus in the Absence of Skin Disease: A Retrospective Study of 197 French Inpatients.

Authors:  Marine Robert; Laurent Misery; Emilie Brenaut
Journal:  Acta Derm Venereol       Date:  2020-09-30       Impact factor: 3.875

4.  Itch in Adult Population with Type 2 Diabetes Mellitus: Clinical Profile, Pathogenesis and Disease-Related Burden in a Cross-Sectional Study.

Authors:  Aleksandra A Stefaniak; Piotr K Krajewski; Dorota Bednarska-Chabowska; Marek Bolanowski; Grzegorz Mazur; Jacek C Szepietowski
Journal:  Biology (Basel)       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.